Suchergebnisse - "Voza, Antonio"

PubPharm (112)

1

Long-Term Outcomes in Severe Community-Acquired Pneumonia

enthalten in: Seminars in respiratory and critical care medicine | 2024

von Carella, F. | Aliberti, S. | Stainer, A. | +2

2

Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics

enthalten in: NPJ vaccines | 2024

von Terzoli, S. | Marzano, P. | Cazzetta, V. | +18

3

Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases : a systematic review

enthalten in: BMJ open respiratory research | 2024

von Bongiovanni, G. | Tonutti, A. | Stainer, A. | +9

4

Extra-Corporeal Membrane Oxygenation in Pregnancy

enthalten in: Journal of clinical medicine | 2024

von Romenskaya, T. | Longhitano, Y. | Mahajan, A. | +4

5

Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors : A case report and literature analysis

enthalten in: World journal of gastroenterology | 2024

von Colapietro, F. | Pugliese, N. | Voza, A. | +2

6

Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients : A Focus on Bleeding Risk and Hospital-Stay Duration

enthalten in: Life (Basel, Switzerland) | 2024

von Desai, A. | Shiffer, D. | Giordano, M. | +7

7

Geriatric Population Triage : The Risk of Real-Life Over- and Under-Triage in an Overcrowded ED: 4- and 5-Level Triage Systems Compared: The CREONTE (Crowding and R E Organization National TriagE) Study

enthalten in: Journal of personalized medicine | 2024

von Savioli, G. | Ceresa, I. | Bressan, M. | +14

8

ANMCO/SIMEU Consensus document on the use of reversal agents of antithrombotic therapies in patients with active bleeding or at high-risk of major bleeding events

enthalten in: Giornale italiano di cardiologia (2006) | 2024

von De Luca, L. | Pugliese, F. | Susi, B. | +13

9

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia : A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

enthalten in: Infectious diseases and therapy | 2023

von Piemonti, L. | Landoni, G. | Voza, A. | +31

10

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

enthalten in: Infectious diseases and therapy | 2023

von Piemonti, L. | Landoni, G. | Voza, A. | +31

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]